Europe Neurological Disorder Drugs Market at a CAGR of CAGR of 6.4% from 2024

The Europe neurological disorder drugs market is remarkably consolidated due to presence of small players who hold a significant share in the overall market. Transparency Market Research has observed Merck & Co., Bayer AG, Astra Zeneca, Novartis AG, and GlaxoSmithKline plc. These top five players held a whopping share of 60.5% in the overall market in 2015.  “These players are expected to focus on expanding their geographical reach and strengthening their pipeline with multiple drug class,” states the lead author of this research report.

According to the research report, the Europe neurological disorder drugs market was valued at US$18.3 bn in 2015 and is expected to reach a valuation of US$32.0 bn by the end of 2024. During the forecast period of 2016 and 2024, the global market is projected to expand at CAGR of 6.4%.

Obtain Report Details @
http://www.transparencymarketresearch.com/europe-neurological-disorder-drugs-market.html

Germany Exhibits CAGR of 6.8% during Forecast Period in Overall Market

The Europe neurological disorder drug market caters to a wide range of diseases. However, analysts anticipate that the cerebrovascular disease segment will progress at a CAGR of 6.9% during the forecast period. On the basis of countries, the market is divided into Germany, France, Italy, Spain, UK, Russia, Switzerland, Netherlands, Poland, and Rest of Europe. Of these, Germany is projected to surpass all others as the country’s neurological disorder drugs is expected to rise at a CAGR of 6.8% between 2016 and 2024.

Aging Population Offers Tremendous Scope for Growth

The remarkable rise in brain-altering diseases has prompted several pharmaceutical companies to tap into the potential market of neurological disorder drugs. The market is expected to thrive due to the rise in investments in research and development of innovative drugs being designed to manage disorders such as Alzheimer’s disease, epilepsy, Parkinson’s disease, cerebrovascular disease, and multiple sclerosis among others. The spike in the geriatric pool of Europe is also a steady factor supporting the growth of the overall market. Growing number of clinical trials are also projected to provide the global market adequate boost in the coming years.

Out of the various drugs for a range of neurological disorders, the cerebrovascular diseases held a dominant share in the global market. Analysts project that this segment will continue to show tremendous progress in the coming years due to growing number patients with complains such as strokes, migraine, and headaches. Statistics show that about 80% of the people in EU5 countries deal with strokes, which is a major part of the cerebrovascular disease. The steady change in the nature of neurological disorders is also projected to play a significant part in the development of the Europe neurological disorder drugs market.

Stringent Regulations for Prescribing Sedatives Hamper Market Growth

The treatment of neurological disorders is exorbitant as it comes with several additional costs of antiepileptic, anticholinergic and hypnotic and sedative drugs. The high cost of research and development has also slowed down the drug development. Furthermore, decline in innovation has resulted in mature product portfolios, which has limited the market in several ways. All of these factors are expected to hamper the growth of the Europe neurological disorder drugs market in the coming years. In addition, the stifling regulations about prescribing sedatives are also expected to restrict market’s growth in the coming few years.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17567

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

North America Porcine Vaccine Market Analysis, Trends and Forecast by 2016 – 2024

The North America porcine vaccines market for features an essentially fragmented marketplace, with the presence of a large number of small and large players. The market, however, is dominated by few; the top four players, namely Merial Animal Health, Zoetis, Inc., Elanco Animal Health, and Merck Animal Health, for instance, collectively held nearly 74% of the overall market in 2015, observes a recent report by Transparency Market Research.

Transparency Market Research estimates that the North America Porcine Vaccine market will exhibit a 5.3% CAGR from 2016 to 2024 and rise from a valuation of US$540.9 mn in 2015 to US$926.2 mn by 2024.

Obtain Report Details @
http://www.transparencymarketresearch.com/north-america-porcine-vaccine-market.html

Factors such as diverse product portfolios, extensive geographical presence, and perceptive acquisitions, as well as intensive research and development and the timely introduction of new vaccines have kept these players ahead of the intense competition. Instances are: The launch of two new swine vaccines by Boehringer Ingelheim Animal Health in 2015: Ingelvac and ReproCyc. The vaccines have been launched to fight against the porcine reproductive and respiratory syndrome (PRRS) virus. Zoetis’ November 2016 launch of Fostera PCV Metastim, a monovalent killed vaccine that protects against porcine circovirus associated diseases (PCVAD).

In terms of disease indication, the diarrhea vaccines segment dominates the North America porcine vaccine market and is expected to account for nearly 55% of the market by 2016. The segment is expected to exhibit a healthy 7.3% CAGR over the period between 2016 and 2024 and gain a much larger, nearly 60% of the overall market, by 2024. In terms of geography, the North America porcine vaccines market is dominated by the U.S., which accounted for over 63% of the overall market in 2015 and is expected to remain the dominant market over the forecast period as well.

Rising Consumption of Meat and Gelatin to Remain Key to Market Growth

The market for porcine vaccines in North America is chiefly driven due to factors such as the rising prevalence of swine diseases and the continuously increasing demand for meat and gelatin in the global market. Owing to globalization and rapid climate changes, the rate of outbreak of various animal diseases, some of which are also transmissible to humans, has picked up pace. Swine being a highly popular source of meat, consumed in increasingly high volumes worldwide, the impact of zoonotic diseases emanating from this class of livestock can be highly devastating for livestock as well as human lives.

North America is the third largest consumer of pork globally. As a result, concerns regarding the spread of zoonotic diseases from swine and related products are well-founded and are rising. These concerns will be key to the increased focus on the health and wellness of swines from livestock farmers and will drive the overall North America porcine vaccine market.

High and Rising Cost of Storing Vaccines to Obstruct Growth

Appropriate storage and handling of vaccines play a key role in ensuring high success rate of a vaccine against any vaccine-preventable disease. The need to strictly adhere to proper storage and handling procedures, lest incur losses worth thousands of dollars in revaccination and wasted vaccine, requires maintaining proper cold chains.

Such cold chains are required to be maintained across all nodes of the supply chain, starting from the manufacturers to the healthcare providers. The high costs of maintaining these storage and handling conditions, which continue to rise with every passing day, are one of the key challenges faced by the North America porcine vaccine market and are expected to restrain the market’s growth to a certain extent over the forecast period.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16976

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Worldwide Radiofrequency Ablation Devices for Pain Management Market to Reach US$1,114.5 mn in 2024

The radiofrequency ablation devices for pain management market features a markedly high level of consolidation, with the top three vendors,  St. Jude Medical, Inc., Halyard Health, Inc., and Boston Scientific Corporation, accounting for a share of over 88% in 2015, observes Transparency Market Research. “These companies have strengthened their hold on the market owing to diversified product portfolios, extensive geographical presence, and strategic acquisitions over the past few years,” states a TMR analyst. Increased focus on emerging economies and increase in product launches are some of the most popular strategies adopted by top players.

Transparency Market Research states that the global radiofrequency ablation devices for pain management market, which valued at US$372.7 mn in 2015, is expected to rise to US$1,114.5 mn in 2024. This translates to a potential 13.0% CAGR over the period between 2016 and 2024.

Obtain Report Details @
http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

In terms of product varieties, the segment of disposable RF products dominated, accounting for a 40% of the overall market in 2015. The segment of RF generators is expected to exhibit expansion at the most promising pace over the forecast period. From a geographic perspective, the market in North America dominated in 2015, accounting for over 40% of the global market in 2015. However, the global market is expected to witness most lucrative growth opportunities in emerging economies across regions such as Asia Pacific and Latin America over the forecast period.

Rising Prevalence of Chronic Pain to Have Sizeable Positive Impact on Market Growth

The rising prevalence of chronic pain conditions and the rising geriatric population of the world are among the key factors leading to the rising global demand for pain management therapies such as the ones that use radiofrequency ablation devices. The global market for these devices for pain management is also highly influenced by the rising demand for minimally invasive procedures across the globe.

Benefits such as lesser post-surgery complications, low chances of side effects, and shorter span of recovery work in favor of minimally invasive surgeries and related devices. Radiofrequency ablation devices for pain management are also gaining increased focus owing to the higher known side effects and lower efficiency of alternate pain relief procedures and therapeutics options such as acupressure, acupuncture, and opioids. The easy availability, cost-effectiveness, and easy access to highly effective radiofrequency ablation devices for pain management have also propelled the market for these devices of late.

Regulatory Hurdles Delaying Approval of New Devices to Hamper Market Growth

The need to comply with stringent laws and regulations set by regulatory authorities that are closely associated with product approvals, clinical trials, design, development, and commercialization hamper the overall development of the market to a sizable extent. Ablation devices come under class III medical device category in Europe and the U.S. Owing to this, the efficacy and safety of devices such as catheters and generators are paramount to gain approval. Strict regulations do not only delay approval, launch, and marketing of these products but also lead to increased prices.

Decisions of regulatory authorities and cost containment measures undertaken by government authorities also have a negative impact on the reimbursement scenario and restrain the market for radiofrequency ablation devices for pain management. Along with these factors, the low costs of several pain management therapeutic options such as anticonvulsants, antidepressants, and NSAIDs also significantly impact and restrain the overall development of the global radiofrequency ablation devices for pain management market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=985

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Competitive Landscape for Worldwide Homeopathy Product Market by Segments – 2024

The global market for homeopathy products features the presence of a large number of small and medium enterprises, with the top five companies cumulatively accounting for merely over 27% of the overall market in 2015, observes Transparency Market Research (TMR) in a recent report. Despite this, the company Boiron Group held over 17.3% of the market in the said year, a share large enough to have a key influence on the market’s direction. Strong presence across regions such as Europe, North America, Asia Pacific, and Middle East and Africa (MEA) has allowed the company to command a prominent position in the global homeopathy products market so far.

However, other notable vendors such as Biologische Heilmittel Heel GmbH, A Nelson & Co Ltd, GMP Laboratories of America, Inc., Standard Homeopathic Company (Hyland’s, Inc.), Washington Homeopathic Products, Inc., and Homeocan inc., struggle to strengthen their hold on the market amid harsh competition. Strategies such as increased focus on robust marketing and promotion activities, proper usage of the highly influential e-commerce marketplace, and expansion across promising regional markets such as Asia Pacific and Middle East and Africa (MEA) could help companies gain more traction in the global market.

Obtain Report Details @
http://www.transparencymarketresearch.com/homeopathy-product-market.html

Middle East and Africa to Provide Promising Growth Opportunities

TMR estimates that the global homeopathy product market, which valued at US$3,867.7 mn in 2015, is expected to reach US$17,486.2 mn by the end of 2024, exhibiting a CAGR of 18.2% over the period between 2016 and 2024. Of the key product varieties in the market, the segment of dilutions is expected to achieve the most promising share in the market’s valuation by the end of forecast period, retaining its dominant position with over 35% of the market by 2024. The segment will also register a strong 17.8% CAGR over the period between 2016 and 2024.

In terms of geography, Europe will continue to account for the most significant share in the market throughout the forecast period but will lose prominence to the Middle East and Africa region in terms of growth rate. Over the period between 2016 and 2024, the Europe market for homeopathy products will exhibit an 18.2% CAGR while the MEA market will expand at a 21.1% CAGR.

Aversion to Allopathic Medicine Expected to Increase Homeopathic Medicine Sales

One of the leading factors augmenting the growth of the global homeopathy products market is the growing concern regarding the high usage of allopathic medicine. “People are becoming increasingly aware of the cumulative side-effects that they may contract after prolonged use of allopathic medicine. This is leading consumers towards alternative treatments, including homeopathy. An independent survey had revealed that US$3 bn was spent on homeopathic medicine within North America alone, in 2007. The market has skyrocketed since then and is on the brink of becoming a mainstay in all key regions,” states a TMR analyst.

Quality Standardization Still Lacking in Homeopathic Medicine Manufacture

There is a considerable lack of quality control within the global homeopathy products market and suppliers are suffering because of it. A massive chunk of the market revenue is gathered by small and medium sized business that are scattered over the key regions, making it very difficult to hold a consolidated effort for quality assurance standards implementation. Every manufacturing industry needs to adhere to good manufacturing practices and so far, the global homeopathy products market is not playing its part to the fullest extent. This is compromising the quality of medicines and products to a great extent, creating negative consumer experiences and reducing demand.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16460

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Wheelchair Accessible Vehicle Converters Market North America Industry Volume By Region 2016 – 2024

According to the research report, the market for wheelchair accessible vehicle converters in North America presented an opportunity worth US$1.74 bn in 2015. Rising at a CAGR of 5.30% during the period from 2016 to 2024, the market is expected to display a substantial growth in its size with the valuation reaching US$3.47 bn by the end of 2024. Full size vehicles have emerged as the leading contributors to this market due to their high prices. Medium size vehicles, however, are expected to lead in terms of sales volume over the next few years.

The North America market for wheelchair accessible vehicle converters demonstrates a fragmented competitive landscape, states a new research study by Transparency Market Research (TMR). The top three players in this market, namely, Vantage Mobility International, BraunAbility, and Mobility Ventures LLC., held more than 65% of the overall market in 2015.

Obtain Report Details @
http://www.transparencymarketresearch.com/north-america-wheelchair-accessible-vehicle-converters-market.html

These players are mostly relying on introducing advanced products in the market for the expansion of their businesses. A shift in their focus towards mergers and acquisitions, in a bid to strengthen their presence, can be observed in the near future, reports the research study.

Side Entry Segment to Experience Strong Rise

The research report has analyzed the North America market for wheelchair accessible vehicle converters on the basis of a number of parameters. On the basis of entry mode, the report classifies this market into side entry and rear entry. Side entry wheelchair accessible vehicles converters has been reporting a much higher demand than the rear entry ones. Researchers anticipate the trend to remain so over the forecast period, thanks to the ability of side entry wheelchair accessible vehicles to enable the patient to drive from a wheelchair or sit in the front passenger position or the driver’s position in a wheelchair. The availability of enter and exit curbside and more storage space is also projected to boost the demand for side entry wheelchair accessible vehicles in the years to come, supporting this segment.

Geographically, the market study has segmented the North America wheelchair accessible vehicle converters market into the U.S. and Canada. The U.S. dominated the overall market in 2015 with a share of nearly 95% and is predicted to continue on the top throughout the period of the forecast. The presence of a massive disabled population base, an upswing in the cases of trauma resulting in disability, and the increasing uptake of wheelchair accessible vehicles, boosted by the government funding and the rising number of awareness initiatives by vehicle converter manufacturers, are also expected to propel the U.S. market for wheelchair accessible vehicle converters in the near future.

Increasing Number of Patients Suffering from Disability of Mobility to Fuel Demand

“The increasing number of patients with disability has influenced the North America market for wheelchair accessible vehicle converters to a great extent,” states the author of this report. In 2015, the number of people using wheelchairs in the U.S. was nearly 3.3 million, which is likely to rise tremendously in the near future on account of the increasing prevalence of disability of mobility among people due to the escalating cases of trauma, accidental injuries, sports injuries, and the surge in the geriatric population. This, as a result, is likely to fuel the demand for wheelchair accessible vehicle converters further over the forecast period.

The rising demand for user-friendly accessible vehicles is also expected to boost this market in the near future. However, the high price of these vehicle may restrict the growth of this market over the next few years, states the research report.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16094

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Worldwide Telemedicine Technologies and Services Market Key Trends & Industry Forecast 2015 – 2023

Telemedicine is the union of health care and telecommunication/information technology aimed at providing assistance to individuals in remote areas who do not have access to health care centers in times of need. Critical care and emergency situations are the primary areas for which telemedicine evolved in practice. The health care industry has always been one of the most lucrative, yet steadily growing, industries across the globe. Requirement of health care is termed as critical and crucial to the sustenance of life, hence considered an important industry. Growth of the telemedicine market is primarily attributed to the rise in quality health care services and products adopted by patients worldwide. The telemedicine market has been largely driven by increasing reimbursements received by health care insurance providers that trickle down to the patient population.

According to a new market research report published by Transparency Market Research “Telemedicine Technologies and Services Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023”, the global telemedicine technologies and services market was valued at US$ 21.1 Bn in 2014 and is estimated to reach US$ 86.7 Bn in 2023, expanding at a CAGR of 17.2% from 2015 to 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/telemedicine-technologies-market.html

The rising geriatric population along with increasing cases of physical disability promotes usage of telemedicine among a significant portion of the global population. However, dearth of medical practitioners dedicated to telemedicine service is a major issue globally. Moreover, growing concern among patients about the inadequacy of virtual consultation presents a challenge to the growth of the telemedicine market. The global telemedicine technologies and services market was valued at US$ 21,124.2 Mn in 2014 and is projected to reach US$ 86,754.8 Mn by 2023 at a CAGR of 17.2% from 2015 to 2023.

Based on component, the telemedicine technologies and services market has been segmented into hardware, software, and services. The hardware segment has been categorized into videoconferencing unit, imaging unit, vital signs unit, ECG, and others. The videoconferencing unit sub-segment accounted for the largest share of the hardware segment in 2014. The segment will continue to dominate the market until 2023 due to increase in preference for videoconferencing units for telemedicine solutions. The imaging unit segment is expected to expand at the highest CAGR from 2015 to 2023 owing to high demand for imaging services, mostly preferred for radiology and digital pathology services, and rapid technological advancements in the imaging segment. However, concerns over confidentiality of patient’s medical information is likely to hamper the growth of the telemedicine technologies and services market during the forecast period.

Based on software, the telemedicine technologies and services market has been segmented into integrated and standalone. The integrated software segment dominated the market in 2014 due to high adoption rate and technological innovations. Telemedicine services (interactive, store and transfer, and chronic care management) is the most promising segment of the telemedicine market owing to worldwide popularity and ability to provide high definition and quality medical services in remote areas. People in developing nations cannot afford technologically advanced products due to financial crisis and low disposable incomes. Hence, they opt for cost-effective and consistent telemedicine services. Therefore, the services segment is likely to gain momentum in developing countries such as India, China, Brazil, and South Africa.

Based on end-user, the global telemedicine technologies and services market has been segmented into telehospital/teleclinic and telehome. The telehospital segment dominated the market primarily due to high adoption rate of technologically advanced and cost-effective innovative telemedicine services and products and rising preference of patients toward telemedicine services for telehospital.

The global telemedicine technologies and services market is characterized by the presence of major companies such as Aerotel Medical Systems Ltd., AMD Global Telemedicine, Inc., General Electric Company, Honeywell International, Inc., and LifeWatch AG.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=108

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Worldwide Regulatory Affairs Outsourcing Market By Analysis of Major Industry Segments 2015 – 2023

The global regulatory affairs outsourcing market had a valuation of US$1.9 bn in 2014. The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 bn by 2023. Rising numbers of low-cost clinical trial centers in emerging economies such as Asia Pacific and Latin America will provide the most lucrative growth opportunities for the market during 2015 to 2023. The market is expected to expand at the highest, 15.8% CAGR, in Asia Pacific during the period. Latin America will follow, exhibiting 11.1% CAGR.

The scenario calls for regulatory affairs service providers to excel on the metrics of timeliness and quality. As health authorities and compliance agencies now accept electronic submissions, technological advancements will also play a crucial role for regulatory affairs service providers in gaining a competitive edge, states a recent report by TMR.

Obtain Report Details @
http://www.transparencymarketresearch.com/global-regulatory-affairs-outsourcing-market.html

In the highly fragmented market for regulatory affairs outsourcing, a very small number of large players have been able to acquire dominant share in the past few years. The top seven companies in the market, including Quintiles Transnational Holdings, Inc., Pharmaceutical Product Development (PPD), LLC, ICON plc, and PAREXEL International Corporation had a combined share of 55% in the global market in 2014. The presence of a large number of small- and medium-size companies in the market grants high bargaining power to buyers/clients. The intense competitive rivalry in the market has increased the number of options to choose from for clients in terms of product differentiation and price.

Cost-efficient Outsource Activities Appeal Companies to Shift from Expensive In-house Regulatory Maintenance

As the medical industry witnesses an increased rate of product innovations from companies wanting to make a mark in the intensely competitive market, investments on R&D activities are skyrocketing. Cost pressures and intense competition in the global market are pushing companies in finding ways of containing costs incurred during the process of undertaking a variety of regulatory operations and practices central to the life sciences industry. Outsourcing, being a cost- and resource-efficient way of cutting costs incurred during the management of the vast data generated during activities such as clinical trials, approvals, and patent approvals, is being increasingly preferred by companies in comparison to in-house data management.

Diverse Regulations Encourage Global Companies to Prefer On-the-ground Expertise

In addition, the presence of strict regulatory framework governing every aspect of development and marketing of medical drugs and devices require that the regulatory documents be in line with defined writing guidelines. This factor has also led to the increased preference for professional service providers focused primarily on handling data related to regulatory affairs, driving the increased need for reliable regulatory affairs outsourcing service providers.

As life sciences companies look forward to spread their business network across the globe, the implications and challenges of managing the diverse and constantly changing local, regional, and national regulations can be overwhelming without on the ground expertise. In this situation, outsourcing regulatory affairs to service providers with a successful global footprint will be the most preferred solution.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3528

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/